Option chain shows key data for Titan Pharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Titan Pharma.

Titan Pharma (NASDAQ:TTNP) Stock, Option Chain

TITAN PHARMA INC

Titan Pharmaceuticals

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Indian OIL

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

BTBT

MYNA

PANW

RERE

TTNP

VIPS

Crude Oil Falls; Palo Alto Networks Shares Jump After Q4 Earnings

Le 2 azioni finanziarie da scaricare ad agosto

Nasdaq Moves Lower; Medtronic Posts Upbeat Earnings

Wall Street US stocks

NDRA

US Stocks Mixed; Lowe&#39;s Cuts FY24 Forecast

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharmaceuticals Inc

Titan Pharmaceuticals Inc Warrants - Class B (18/10/2024)

Under Nasdaq rules, the Company has 60 calendar days from receipt of the 5250 Notice or until January 21, 2025, to submit a plan to regain compliance with the Listing Rule.&nbsp;

Titan Pharmaceuticals Gets Non-Compliance Notice From Nasdaq

U.S. stocks traded mostly lower toward the end of trading, with the S&amp;P 500 falling around 0.1% on Tuesday.
The Dow traded down 0.12% to 40,849.39 while the NASDAQ fell 0.11% to 17,856.43. The S&amp;P 500 also fell, dropping, 0.07% to 5,604.36.
Check This Out: <a href="https://www.benzinga.com/news/24/08/40460726/apple-alphabet-and-2-other-stocks-insiders-are-selling">Apple, Alphabet And 2 Other Stocks Insiders Are Selling</a>
Leading and Lagging Sectors Health care shares climbed by 0.4% on Tuesday.
In trading on Tuesday, energy shares fell by 2.4%.
Top Headline
Shares of Palo Alto Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) gained around 9% on Tuesday after the company reported better-than-expected results for its fourth quarter and issued strong guidance.
Palo Alto&#8217;s board authorized an additional $500 million for share repurchases, bringing the company&#8217;s remaining buyback authorization up to $1 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>InMed Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INM#NASDAQ">INM</a>) shares shot up 194% to $0.4361 after the company announced that INM-901 will be used in its development programs for Alzheimer&#8217;s Disease.</li>
<li>Shares of Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) got a boost, surging 17% to $3.4850 after the company reported better-than-expected second-quarter sales results. Also, the company announced a binding term sheet with Boosteroid.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares were also up, gaining 94% to $9.71. Titan Pharmaceuticals entered into merger and contribution and share exchange agreement regarding a business combination with KE Sdn. Bhd.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares dropped 54% to $1.92 after the company cut its FY24 revenue guidance.</li>
<li>Shares of ATRenew Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NASDAQ">RERE</a>) were down 13% to $2.46 following second-quarter results.</li>
<li>Vipshop Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) was down, falling 17% to $11.60 after the company reported second-quarter results and guided third-quarter revenues down approximately 5-10%.</li>
</ul>
Commodities In commodity news, oil traded down 0.7% to $73.82 while gold traded up 0.5% at $2,553.30.
Silver traded up 0.5% to $29.46 on Tuesday, while copper fell 0.8% to $4.1490.
Euro zone
European shares closed lower today. The eurozone's STOXX 600 slipped 0.45%, Germany's DAX fell 0.35% and France's CAC 40 slipped 0.22%. Spain's IBEX 35 Index fell 0.13%, while London's FTSE 100 fell 1%.
The annual inflation rate in the Eurozone increased to 2.6% in July from 2.5% in the prior month, while current account surplus rose to €52.4 billion in June from €32.4 billion a year ago. Italy&#8217;s current account surplus widened to EUR 4,885 billion in June from EUR 1,248 billion in the year-ago period. Producer prices in Germany fell by 0.8% year-over-year in July.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 gaining 1.80%, Hong Kong's Hang Seng Index falling 0.33%, China's Shanghai Composite Index falling 0.93% and India's BSE Sensex rising 0.47%.
The annual inflation rate in Hong Kong increased to 2.5% in July from 1.5% in the prior month. The People&#8217;s Bank of China kept key lending rates unchanged at the recent fixing.
Economics
No major economic reports are scheduled for release today.
Now Read This:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40461302/top-3-tech-stocks-which-could-rescue-your-portfolio-this-quarter"> </a>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40461302/top-3-tech-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday.
The Dow traded down 0.10% to 40,854.31 while the NASDAQ fell 0.15% to 17,850.34. The S&amp;P 500 also fell, dropping, 0.06% to 5,604.70.
Check This Out: <a href="https://www.benzinga.com/news/24/08/40460726/apple-alphabet-and-2-other-stocks-insiders-are-selling">Apple, Alphabet And 2 Other Stocks Insiders Are Selling</a>
Leading and Lagging Sectors Health care shares climbed by 0.5% on Tuesday.
In trading on Tuesday, energy shares fell by 1%.
Top Headline
Medtronic Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) reported better-than-expected results for its first quarter on Tuesday.
The company posted first-quarter 2025 sales of $7.92 billion, beating the consensus of $7.89 billion. The medical device maker reported adjusted EPS of $1.23, beating the consensus of $1.20. Revenue increased 2.8% year over year, as reported, and 5.3% organic.
Medtronic revised its fiscal year 2025 adjusted EPS guidance to $5.42 – $5.50, compared to prior guidance of $5.40 – $5.50 and consensus of $5.44. The company sees fiscal year 2025 organic revenue growth of 4.5% – 5% compared to prior guidance of 4% – 5%.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>InMed Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INM#NASDAQ">INM</a>) shares shot up 250% to $0.5075 after the company announced that INM-901 will be used in its development programs for Alzheimer&#8217;s Disease.</li>
<li>Shares of Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) got a boost, surging 16% to $3.47 after the company reported better-than-expected second-quarter sales results. Also, the company announced a binding term sheet with Boosteroid.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares were also up, gaining 108% to $10.37. Titan Pharmaceuticals entered into merger and contribution and share exchange agreement regarding a business combination with KE Sdn. Bhd.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares dropped 54% to $1.93 after the company cut its FY24 revenue guidance.</li>
<li>Shares of ATRenew Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NASDAQ">RERE</a>) were down 12% to $2.5066 following second-quarter results.</li>
<li>Vipshop Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) was down, falling 10% to $12.57 after the company reported second-quarter results and guided third-quarter revenues down approximately 5-10%.</li>
</ul>
Commodities In commodity news, oil traded up 0.8% to $74.96 while gold traded up 1.1% at $2,568.90.
Silver traded up 2% to $29.875 on Tuesday, while copper rose 0.2% to $4.1875.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.22%, Germany's DAX fell 0.09% and France's CAC 40 slipped 0.01%. Spain's IBEX 35 Index fell 0.32%, while London's FTSE 100 fell 0.85%.
The annual inflation rate in the Eurozone increased to 2.6% in July from 2.5% in the prior month, while current account surplus rose to €52.4 billion in June from €32.4 billion a year ago. Italy&#8217;s current account surplus widened to EUR 4,885 billion in June from EUR 1,248 billion in the year-ago period. Producer prices in Germany fell by 0.8% year-over-year in July.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 gaining 1.80%, Hong Kong's Hang Seng Index falling 0.33%, China's Shanghai Composite Index falling 0.93% and India's BSE Sensex rising 0.47%.
The annual inflation rate in Hong Kong increased to 2.5% in July from 1.5% in the prior month. The People&#8217;s Bank of China kept key lending rates unchanged at the recent fixing.
Economics
No major economic reports are scheduled for release today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40461302/top-3-tech-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

Titan Pharmaceuticals Inc Shares Resume Trade

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 80 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.19% to 40,818.40 while the NASDAQ rose 0.05% to 17,884.96. The S&amp;P 500 also rose, gaining, 0.01% to 5,609.04.
Check This Out: <a href="https://www.benzinga.com/news/24/08/40460726/apple-alphabet-and-2-other-stocks-insiders-are-selling">Apple, Alphabet And 2 Other Stocks Insiders Are Selling</a>
Leading and Lagging Sectors Health care shares climbed by 0.5% on Tuesday.
In trading on Tuesday, energy shares fell by 0.6%.
Top Headline
Lowe's Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) reported stronger-than-expected second-quarter earnings, but revealed a decline in comparable sales and revised its FY24 outlook downward.
The company reported adjusted earnings per share of $4.10, beating the analyst consensus of $3.99. Quarterly revenues totaled $23.586 billion, missing the street view of $24.013 billion.
Lowe's revised its FY24 outlook, citing lower-than-expected DIY sales and a pressured macroeconomic environment. The company now projects total sales between $82.7 billion and $83.2 billion, down from the previous range of $84 billion to $85 billion ($84.481 billion estimate). Adjusted EPS is projected to be between $11.70 and $11.90 (estimate: $12.22), compared to the earlier range of $12.00 to $12.30.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>InMed Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INM#NASDAQ">INM</a>) shares shot up 338% to $0.6730 after the company announced that INM-901 will be used in its development programs for Alzheimer&#8217;s Disease.</li>
<li>Shares of Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) got a boost, surging 224% to $1.88. Treasure Global recently submitted request to withdraw S-1 registration statement.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares were also up, gaining 108% to $10.40. Titan Pharmaceuticals entered into merger and contribution and share exchange agreement regarding a business combination with KE Sdn. Bhd.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares dropped 55% to $1.8999 after the company cut its FY24 revenue guidance.</li>
<li>Shares of ENDRA Life Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) were down 41% to $0.9532. ENDRA Life Sciences recently announced a 1-for-50 reverse stock split.</li>
<li>BurgerFi International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) was down, falling 31% to $0.2251.</li>
</ul>
Commodities In commodity news, oil traded down 0.3% to $74.16 while gold traded up 1% at $2,567.50.
Silver traded up 2.2% to $29.955 on Tuesday, while copper rose 0.5% to $4.2015.
Euro zone
European shares were lower today. The eurozone's STOXX 600 slipped 0.3%, Germany's DAX fell 0.2% and France's CAC 40 slipped 0.1%. Spain's IBEX 35 Index fell 0.3%, while London's FTSE 100 fell 0.9%.
The annual inflation rate in the Eurozone increased to 2.6% in July from 2.5% in the prior month, while current account surplus rose to €52.4 billion in June from €32.4 billion a year ago. Italy&#8217;s current account surplus widened to EUR 4,885 billion in June from EUR 1,248 billion in the year-ago period. Producer prices in Germany fell by 0.8% year-over-year in July.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 gaining 1.80%, Hong Kong's Hang Seng Index falling 0.33%, China's Shanghai Composite Index falling 0.93% and India's BSE Sensex rising 0.47%.
The annual inflation rate in Hong Kong increased to 2.5% in July from 1.5% in the prior month. The People&#8217;s Bank of China kept key lending rates unchanged at the recent fixing.
Economics
No major economic reports are scheduled for release today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40461302/top-3-tech-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

US Stocks Mixed; Lowe's Cuts FY24 Forecast

Titan Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 87.0%

Titan Pharmaceuticals Shares Resume Trade

PANW: 5% &#x7C; <a href="https://www.benzinga.com//node/40457641">Palo Alto Networks shares are trading higher following better-than-expected Q4 financial results, issued strong guidance and authorized an additional $500 million for repurchase. Multiple analysts raised their price targets on the stock following the report.</a>
&nbsp;
TTNP: 141% &#x7C; <a href="https://www.benzinga.com//node/40449062">Titan Pharmaceuticals Enters Merger And Contribution And Share Exchange Agreement Regarding A Business Combination With KE Sdn. Bhd.</a>
&nbsp;
AUUD: 162% &#x7C; <a href="https://www.benzinga.com//node/40457688">Auddia Inc. Announces The Launch Of faidr 3.1</a>

Movers

AUUD

Market-Moving News for August 20th

Shares of Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter sales results. Also, the company announced a binding <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40450880/bit-digital-reports-mixed-q2-results-eps-miss-revenue-up-80">term sheet with Boosteroid.</a>
Bit Digital reported quarterly losses of nine cents per share, which missed the analyst consensus estimate of losses of three cents per share. Quarterly revenue came in at $29 million, beating the analyst consensus estimate of $26.09 million by 11.16% and representing a 220.87% increase year-over-year.
Bit Digital shares jumped 11% to $3.32 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Treasure Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) rose 122.4% to $1.29 in today's pre-market trading. Treasure Global recently submitted request to withdraw S-1 registration statement.</li>
<li>Heramba Electric plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PITA#NASDAQ">PITA</a>) gained 127% to $4.76 in pre-market trading after jumping around 10% on Monday.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) gained 105.6% to $10.25 in pre-market trading. Titan Pharmaceuticals entered into merger and contribution and share exchange agreement regarding a business combination with KE Sdn. Bhd.</li>
<li>Tantech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TANH#NASDAQ">TANH</a>) shares rose 60.1% to $0.2036 in pre-market trading.</li>
<li>MicroAlgo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) gained 30.5% to $0.7180 in pre-market trading after gaining around 12% on Monday.</li>
<li>MicroCloud Hologram Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLO#NASDAQ">HOLO</a>) gained 28.1% to $0.5340 in pre-market trading after climbing 43% on Monday.</li>
<li>Actelis Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) gained 22.3% to $1.59 in pre-market trading after the company announced a strategic partnership with an advanced cybersecurity provider to develop and deliver a novel, AI-Powered SaaS offering, under Actelis&#8217; &#8216;Cyber Aware Networking&#8217; initiative.</li>
<li>Golden Sun Health Technology Group Limited  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSUN#NASDAQ">GSUN</a>) gained 19.1% to $6.62 in pre-market trading after dipping 25% on Monday.</li>
<li>Hawaiian Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HA#NASDAQ">HA</a>) shares gained 10.1% to $17.48 in pre-market trading. The proposed $1.9 billion merger between Alaska Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALK#NYSE">ALK</a>) and Hawaiian Airlines by Hawaiian Holdings has received clearance from the U.S. Justice Department, marking a significant step forward in the deal announced eight months ago. The merger is now pending approval from the U.S. Transportation Department.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Alzamend Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) shares fell 29.1% to $4.15 in pre-market trading. Alzamend Neuro shares jumped 188% on Monday after the company announced that it is partnering with Massachusetts General Hospital as its contract research organization to conduct first of its kind Phase II clinical study of AL001 for treatment of patients with PTSD.</li>
<li>Cingulate Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CING#NASDAQ">CING</a>) shares declined 25.6% to $9.52 in pre-market trading. Cingulate shares dipped 28% on Monday after the company increased the maximum offering price for common stock under its sales agreement from $8.47 million to $11.33 million.</li>
<li>Sidus Space, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) declined 22.1% to $2.97 in pre-market trading. Sidus Space reported quarterly losses of 99 cents per share and $927,570 in revenue for the second quarter.</li>
<li>NuCana plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares fell 20.5% to $7.69 in pre-market trading. NuCana shares surged 181% on Monday after Oppenheimer reiterated an outperform rating on the stock and maintained a $150 price target, citing the company&#8217;s randomized Phase 2 trial in metastatic colorectal cancer as a key catalyst.</li>
<li>GeoVax Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOVX#NASDAQ">GOVX</a>) fell 18.8% to $5.80 in today's pre-market trading. On Monday, Noble Capital Markets maintained an Outperform rating on the stock and raised its price target from $6 to $10.</li>
<li>Sonder Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOND#NASDAQ">SOND</a>) fell 16.6% to $5.04 in pre-market trading. Sonder shares surged over 130% on Monday after the company announced a long-term licensing agreement with Marriott. Additionally, the company secured $146 million in additional liquidity.</li>
<li>Fluent Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) fell 16.3% to $2.51 in pre-market trading as the company reported worse-than-expected second-quarter financial results on Monday.</li>
<li>Electra Battery Materials Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELBM#NASDAQ">ELBM</a>) shares dipped 14.2% to $0.4797 in pre-market trading. Electra Battery Materials shares surged 50% on Monday after the Department of Defense announced it awarded the company a $20 million contract to complete an industrial scale hydrometallurgical plant and establish production of cobalt sulfate.</li>
<li>Vipshop Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) shares declined 7.2% to $13.00 in pre-market trading after reporting second-quarter results.</li>
<li>ATRenew Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) shares fell 6.7% to $2.65 in pre-market trading following second-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40454461/s-p-500-nasdaq-extend-gains-for-8th-consecutive-session-investor-sentiment-improves-but-greed-index">S&amp;P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

ALZN

ASNS

CING

ELBM

FLNT

GOVX

GSUN

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

MLGO

NCNA

PITA

SIDU

SOND

TANH

Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

Trading Halt: Halt status updated at 4:35:00 PM ET: Quotation Resumption: News and Resumption Times

Titan Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) ("Titan") today announced that it has entered into a Merger and Contribution and Share Exchange Agreement (the "Merger Agreement") regarding a business combination with KE Sdn. Bhd. ("KE"). The Merger Agreement was approved by Titan's board of directors (the "Board"). If the Merger Agreement is approved by the stockholders of Titan and KE (and the other closing conditions are satisfied or waived in accordance with the Merger Agreement), and upon consummation of the transactions contemplated by the Merger Agreement (the&nbsp;"Closing"), Titan will be combined with KE in a "reverse merger" transaction consisting of two steps: &nbsp;
<ol>
<li>TTNP Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of&nbsp;BSKE Ltd. ("BSKE"), a Cayman Islands exempted company, will merge with and into Titan (the&nbsp;"Merger"); the separate existence of Merger Sub will cease; and Titan will be the surviving corporation of the Merger and a direct wholly owned subsidiary of BSKE. 
<ol>
<li>Within five business days of the filing by Titan and BSKE of a proxy statement/prospectus relating to the proposed transaction, shareholders of KE may elect to enter into a share exchange agreement (the "Share Exchange Agreement") with Titan and BSKE, pursuant to which, immediately following the Merger, each KE shareholder entering into the Share Exchange Agreement will contribute and exchange all of his KE shares in exchange for ordinary shares of BSKE.&nbsp;Titan may terminate the Merger Agreement if fewer than all KE shareholders enter into the Share Exchange Agreement within the specified period.</li>
</ol>
</li>
</ol>

Titan Pharmaceuticals Enters Merger And Contribution And Share Exchange Agreement Regarding A Business Combination With KE Sdn. Bhd.

Trading Halt: Halted at 4:00:11 p.m. ET - Trading Halt: Halt News Pending

<h3>Gainers</h3>
<ul>
<li>CareCloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCLD#NASDAQ">CCLD</a>) stock moved upwards by 80.5% to $2.27 during Monday's regular session. The company's market cap stands at $36.6 million. </li>
<li>Novavax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) stock rose 42.17% to $12.62. The market value of their outstanding shares is at $1.7 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Macrogenics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) stock rose 27.79% to $4.23. The market value of their outstanding shares is at $264.6 million. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>Chromocell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) shares moved upwards by 25.68% to $2.3. The market value of their outstanding shares is at $13.5 million. </li>
<li>Omega Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMGA#NASDAQ">OMGA</a>) shares moved upwards by 24.01% to $2.43. The market value of their outstanding shares is at $134.0 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares increased by 21.74% to $8.4. The market value of their outstanding shares is at $7.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares declined by 40.1% to $0.84 during Monday's regular session. The company's market cap stands at $5.1 million. </li>
<li>Applied DNA Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APDN#NASDAQ">APDN</a>) stock fell 22.03% to $2.69. The market value of their outstanding shares is at $2.3 million. The company's, Q2 earnings came out yesterday. </li>
<li>Heart Test Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSCS#NASDAQ">HSCS</a>) stock declined by 19.66% to $0.07. The company's market cap stands at $4.6 million. </li>
<li>Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) shares decreased by 16.76% to $7.7. The market value of their outstanding shares is at $65.4 million. As per the press release, Q3 earnings came out today. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) stock declined by 16.12% to $1.54. The market value of their outstanding shares is at $6.9 million. </li>
<li>Fortrea Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRE#NASDAQ">FTRE</a>) shares declined by 15.78% to $27.82. The company's market cap stands at $2.4 billion. The company's, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APDN

BNTC

CCLD

CHRO

FTRE

HSCS

MGNX

NVAX

OGEN

OMGA

RNAZ

12 Health Care Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>NRX Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) shares increased by 39.5% to $2.93 during Monday's regular session. The company's market cap stands at $30.9 million. </li>
<li>TC BioPharm (Holdings) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) stock moved upwards by 35.61% to $1.98. The company's market cap stands at $6.3 million. </li>
<li>Outset Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OM#NASDAQ">OM</a>) stock rose 26.15% to $3.96. The company's market cap stands at $204.8 million. </li>
<li>Nanoviricides (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NNVC#AMEX">NNVC</a>) stock moved upwards by 25.66% to $1.42. The market value of their outstanding shares is at $16.7 million. </li>
<li>Chemomab Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMMB#NASDAQ">CMMB</a>) stock rose 22.16% to $0.9. The market value of their outstanding shares is at $12.8 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares moved upwards by 22.09% to $8.4. The market value of their outstanding shares is at $7.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) shares decreased by 86.3% to $0.55 during Monday's regular session. The market value of their outstanding shares is at $33.6 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>GlycoMimetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NASDAQ">GLYC</a>) stock declined by 79.04% to $0.38. The market value of their outstanding shares is at $24.7 million. </li>
<li>EyePoint Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYPT#NASDAQ">EYPT</a>) shares declined by 39.37% to $11.97. The market value of their outstanding shares is at $623.4 million. </li>
<li>Acutus Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFIB#NASDAQ">AFIB</a>) stock fell 27.1% to $0.11. The company's market cap stands at $3.1 million. </li>
<li>Integra Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) shares declined by 20.46% to $22.98. The company's market cap stands at $1.8 billion. The company's, Q1 earnings came out today. </li>
<li>Helius Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSDT#NASDAQ">HSDT</a>) shares fell 14.81% to $2.44. The company's market cap stands at $2.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AFIB

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

EYPT

GLYC

HSDT

IART

LYRA

NNVC

NRXP

TCBP

<h3>Gainers</h3>
<ul>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) stock moved upwards by 98.4% to $3.83 during Thursday's regular session. The company's market cap stands at $200.6 million. The company's, Q1 earnings came out yesterday. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) stock moved upwards by 40.1% to $0.19. The market value of their outstanding shares is at $1.2 million. </li>
<li>Sensei Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) shares increased by 40.05% to $1.76. The company's market cap stands at $44.2 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) shares rose 36.26% to $1.42. The company's market cap stands at $9.3 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares moved upwards by 32.35% to $0.3. The company's market cap stands at $85.5 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) shares moved upwards by 25.37% to $8.4. The market value of their outstanding shares is at $7.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Accuray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) shares fell 27.6% to $1.57 during Thursday's regular session. The market value of their outstanding shares is at $155.6 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) shares fell 17.62% to $5.8. The market value of their outstanding shares is at $217.3 million. </li>
<li>Elevation Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) stock fell 11.26% to $3.55. The company's market cap stands at $172.7 million. The company's, Q1 earnings came out today. </li>
<li>Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) stock fell 11.13% to $70.24. The company's market cap stands at $10.2 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock fell 10.97% to $1.34. The company's market cap stands at $46.4 million. </li>
<li>BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) stock declined by 10.84% to $3.0. The market value of their outstanding shares is at $144.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARAY

BCAB

BRKR

ELEV

JAGX

NUWE

OCEA

SNSE

SYRA

12 Health Care Stocks Moving In Thursday's Intraday Session

Offerings

Titan Pharmaceuticals Files FormRW Co Decided Not To Pursue The Offering Due To Market Conditions And No Longer Wishes To Conduct A Public Offering Of Securities At This Time, No Securities Covered By The Registration Statement Have Been Issued Or Sold.

<h3>Gainers</h3>
<ul>
<li>Mobile-health Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) shares rose 15.0% to $31.35 during Friday's after-market session. The company's market cap stands at $1.0 billion. </li>
<li>Galera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTX#NASDAQ">GRTX</a>) stock increased by 9.13% to $0.2. The market value of their outstanding shares is at $10.9 million. </li>
<li>Innovative Eyewear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) shares increased by 8.54% to $0.26. The company's market cap stands at $3.4 million. </li>
<li>China Pharma Holdings, Inc. Common Stock (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CPHI#AMEX">CPHI</a>) stock moved upwards by 6.7% to $0.34. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares increased by 6.17% to $0.17. The market value of their outstanding shares is at $8.4 million. </li>
<li>Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) shares increased by 6.04% to $1.04. The company's market cap stands at $264.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vaxxinity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VAXX#NASDAQ">VAXX</a>) shares decreased by 10.7% to $0.43 during Friday's after-market session. The company's market cap stands at $53.8 million. </li>
<li>Titan Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTNP#NASDAQ">TTNP</a>) stock declined by 9.26% to $6.37. The market value of their outstanding shares is at $5.8 million. </li>
<li>Tiziana Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSA#NASDAQ">TLSA</a>) shares decreased by 8.24% to $0.61. The company's market cap stands at $61.4 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) shares decreased by 7.17% to $0.4. The market value of their outstanding shares is at $4.2 million. </li>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) stock decreased by 6.94% to $0.33. The company's market cap stands at $41.7 million. </li>
<li>Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) stock fell 5.67% to $6.5. The market value of their outstanding shares is at $243.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADAP

CLDI

CLNN

CPHI

GRTX

LUCY

MNDR

SNGX

TLSA

VAXX

12 Health Care Stocks Moving In Friday's After-Market Session

Shares of Agenus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agen#NASDAQ">AGEN</a>) fell sharply during Monday&rsquo;s session.
Agenus disclosed a 1-for-20 reverse stock split of common stock.
Agenus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agen#NASDAQ">AGEN</a>) declined 17% to $0.4181 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Auddia Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auud#NASDAQ">AUUD</a>) shares jumped 231.7% to $4.72 after the company announced the USPTO awarded it with U.S. Patent 11,935,520 for the core AI technology the company uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers.</li>
<li>Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) shares climbed 93.2% to $4.2499 after the company submitted paperwork for a share offering.</li>
<li>UTime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wto#NASDAQ">WTO</a>) gained 56.8% to $0.29 after the company completed a private placement.</li>
<li>U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) climbed 48% to $6.96 after the company announced announced that its battery-swapping and sharing model for two-wheeled and light four-wheeled electric vehicles is poised for a formal commercial rollout in Wuhu, Anhui Province, China.</li>
<li>Arrowroot Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arrw#NASDAQ">ARRW</a>) rose 38.2% to $19.53.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) jumped 33.8% to $79.30 after jumping around 77% on Friday.</li>
<li>TechPrecision Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpcs#NASDAQ">TPCS</a>) rose 29.8% to $4.2837 after the company announced the termination of the agreement to acquire Votaw Precision Technologies.</li>
<li>Adlai Nortye Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anl#NASDAQ">ANL</a>) gained 27.9% to $10.68.</li>
<li>Connexa Sports Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxa#NASDAQ">CNXA</a>) surged 26.8% to $0.3801.</li>
<li>AXT, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axti#NASDAQ">AXTI</a>) rose 25.7% to $3.9089. AXT said it sees preliminary revenue of $22.4 million to $22.7 million for the first quarter.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttnp#NASDAQ">TTNP</a>) climbed 24.4% to $8.70.</li>
<li>Apartment Income REIT Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/airc#NYSE">AIRC</a>) gained 22.6% to $38.47. Blackstone Real Estate will take AIR Communities private for approximately $10 billion.</li>
<li>GD Culture Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdc#NASDAQ">GDC</a>) rose 22% to $1.1195.</li>
<li>Outset Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/om#NASDAQ">OM</a>) gained 19.4% to $2.4492. BTIG analyst Maria Thibault initiated coverage on Outset Medical with a Buy rating and announced a price target of $6.</li>
<li>Dogness (International) Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dogz#NASDAQ">DOGZ</a>) gained 18.2% to $9.53.</li>
<li>Galmed Pharmaceuticals Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glmd#NASDAQ">GLMD</a>) rose 17.6% to $0.3999. Last week, Galmed Pharmaceuticals filed annual report on Form 20-F for the fiscal year ended Dec. 31, 2023.</li>
<li>Ducommun Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dco#NYSE">DCO</a>) surged 17.5% to $57.11 after the company confirmed that its Board of Directors received an unsolicited non-binding indication of interest from Albion River LLC.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) rose 13.8% to $6.60.</li>
<li>Perpetua Resources Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ppta#NASDAQ">PPTA</a>) climbed 13.5% to $5.40 after the company announced it received indication for up to $1.8 billion in financing from the Export-Import Bank of the United States for the Stibnite Gold Project.</li>
<li>AltC Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alcc#NASDAQ">ALCC</a>) gained 13.1% to $14.82. Oklo signed a LOI to supply 50 megawatts of power to Diamondback Energy.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) rose 12.7% to $1.8697.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 10.9% to $1,595.72 amid a rise in Bitcoin.</li>
<li>Model N, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/modn#NYSE">MODN</a>) rose 10.7% to $30.00 after the company announced it will be acquired by Vista Equity Partners for $1.25 billion.</li>
<li>A-Mark Precious Metals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amrk#NASDAQ">AMRK</a>) gained 10.3% to $36.10.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) surged 8.1% to $260.41 amid a rise in the price of Bitcoin.</li>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) gained 8% to $1.1119.</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehl#NASDAQ">AEHL</a>) shares rose 7.4% to $1.60 after declining 5% on Friday. On April 1, Antelope Enterprise announced preliminary full year 2023 revenue of $70.4 million.</li>
<li>Fastly, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fsly#NASDAQ">FSLY</a>) gained 5.9% to $13.27. Piper Sandler analyst James Fish upgraded Fastly from Neutral to Overweight and lowered the price target from $19 to $16.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>22nd Century Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xxii#NASDAQ">XXII</a>) fell 45.4% to $1.95. 22nd Century Group shares jumped over 140% on Friday after the company signed a new contract manufacturing agreement for the production of branded conventional cigarette products.</li>
<li>Perion Network Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/peri#NASDAQ">PERI</a>) dipped 36% to $13.51 after the company slashed FY24 revenue guidance.</li>
<li>MediaCo Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdia#NASDAQ">MDIA</a>) fell 29.1% to $2.75. Shares of MediaCo Holding jumped 177% on Friday after a 13D amended filing showed Standard General L.P. reported a 95.2% stake in the company as of April 1, 2024.</li>
<li>SuperCom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spcb#NASDAQ">SPCB</a>) fell 24.3% to $0.2175.</li>
<li>Selina Hospitality PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slna#NASDAQ">SLNA</a>) fell 23.7% to $0.0420.</li>
<li>DatChat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dats#NASDAQ">DATS</a>) fell 20.5% to $1.16.</li>
<li>HUB Cyber Security Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) dipped 18% to $1.26. HUB Cyber Security recently announced $8 million in financing via a straight debt arrangement.</li>
<li>Agenus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agen#NASDAQ">AGEN</a>) declined 17% to $0.4181. Agenus disclosed a 1-for-20 reverse stock split of common stock.</li>
<li>TRACON Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) fell 16.2% to $0.2139.</li>
<li>Conifer Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnfr#NASDAQ">CNFR</a>) dipped 15.9% to $0.8995. Cullen/Frost Bankers is scheduled to host a conference call on Thursday, April 25, 2024 to discuss first quarter 2024 earnings.</li>
<li>HWH International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwh#NASDAQ">HWH</a>) fell 15.6% to $1.3408.</li>
<li>Murano Global Investments Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrno#NASDAQ">MRNO</a>) fell 11.8% to $9.79.</li>
<li>Globavend Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gvh#NASDAQ">GVH</a>) shares fell 11.2% to $1.4567 after jumping 57% on Friday.</li>
<li>CCSC Technology International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cctg#NASDAQ">CCTG</a>) shares fell 11.2% to $3.00 after surging around 28% on Friday.</li>
<li>Reliance Global Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reli#NASDAQ">RELI</a>) fell 10.8% to $0.4327. Reliance Global, last week, reported FY23 earnings.</li>
<li>ZOOZ Power Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zooz#NASDAQ">ZOOZ</a>) fell 9.5% to $3.6675.</li>
<li>Douglas Dynamics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plow#NYSE">PLOW</a>) fell 8.2% to $22.03. Baird analyst Timothy Wojs downgraded Douglas Dynamics from Outperform to Neutral and lowered the price target from $36 to $25.</li>
<li>Trump Media &amp; Technology Group Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/djt#NYSE">DJT</a>) fell 7.4% to $37.60.</li>
<li>Paramount Global (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/para#NASDAQ">PARA</a>) fell 7.1% to $11.12.</li>
<li>Dell Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dell#NYSE">DELL</a>) fell 4.1% to $127.22.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/04/38141299/this-analyst-with-86-accuracy-rate-sees-more-than-16-upside-in-intel-here-are-5-stock-picks-for-last"> This Analyst With 86% Accuracy Rate Sees More Than 16% Upside In Intel - Here Are 5 Stock Picks For Last Week From Wall Street&#39;s Most Accurate Analysts</a>

Penny Stocks

Small Cap

AEHL

AGEN

AIRC

ALCC

AMRK

ARRW

AXTI

BCAN

CCTG

CNFR

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

COIN

DATS

DELL

DOGZ

DXYZ

FSLY

GLMD

HUBC

LGVN

MDIA

MESO

MODN

MRNO

MSTR

PARA

PERI

PLOW

PPTA

RELI

SLNA

SPCB

TCON

TPCS

UCAR

XXII

ZOOZ

Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session

- SEC 13D/Amended Filing
&nbsp;
After giving effect to these changes in membership, as of April 2, 2024, four of the board's seven directors had been nominated by the reporting persons. The reporting persons expect to propose to the Issuer a business combination with KE Sdn. Bhd., a Malaysian company. Any such transaction would be subject to execution of definitive documents negotiated between the reporting persons and a committee of independent directors of the Issuer. This report does not constitute an offer of any securities for sale.

The Sire Group Ltd Says Expect To Propose To Titan Pharmaceuticals Inc A Business Combination With KE Sdn. Bhd

Galectin Therapeutics, Titan Pharmaceuticals, Outset Medical among healthcare movers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Titan Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/ttnp-stock-quote/">TTNP</a>) just reported results for the first quarter of 2024.<ul><li>Titan Pharmaceuticals reported earnings per share of -$1.24.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/ttnp-stock-earnings-titan-pharmaceuticals-for-q1-of-2024/">TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q1 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Titan Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/ttnp-stock-quote/">TTNP</a>) just reported results for the fourth quarter of 2023.<ul><li>Titan Pharmaceuticals reported earnings per share of -5 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/ttnp-stock-earnings-titan-pharmaceuticals-for-q4-of-2023/">TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q4 2023

Earnings week ahead: NVIDIA, Target, Zoom Video, Snowflake and more

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Titan Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/ttnp-stock-quote/">TTNP</a>) just reported results for the second quarter of 2024.<ul><li>Titan Pharmaceuticals reported earnings per share of -$2.29.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/ttnp-stock-earnings-titan-pharmaceuticals-for-q2-of-2024/">TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q2 2024

Titan Pharmaceuticals (TTNP) just unveiled an update. Titan Pharmaceuticals, Inc. (TTNP) has entered into a significant Merger Agreement that will ...

Titan Pharmaceuticals Embarks on Strategic Merger and Restructuring

Microcap Titan Pharma soars after hours on merger with Malaysian company

Titan Pharmaceuticals announces non-compliance notice from Nasdaq

Titan Pharmaceuticals (TTNP) reported that it received a notice on November 22 from the Listing Qualifications Department of The Nasdaq Stock Marke...

Titan Pharmaceuticals receives Nasdaq notice of non-compliance

Titan Pharmaceuticals ( ($TTNP) ) has issued an announcement. Chay Weei Jye has been appointed as the new CEO, bringing extensive IT leadership exp...

Comments

Titan Pharma

Titan Pharma (TTNP) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga